Indraprastha Medical Corporation
367.75
-10.80(-2.85%)
Market Cap₹3,371.27 Cr
PE Ratio18.95
Company Performance:
1D-2.85%
1M-13.42%
6M-32.91%
1Y-10.13%
5Y+362.87%
View Company Insightsright
More news about Indraprastha Medical Corporation
18Feb 26
Indraprastha Medical Corporation Limited Announces Postal Ballot for Independent Directors' Appointment
Indraprastha Medical Corporation Limited has issued a postal ballot notice for shareholder approval of Independent Director appointments. The e-voting process runs from February 19 to March 20, 2026, covering re-appointment of three existing Independent Directors for second five-year terms and appointment of one new Independent Director. All resolutions require special resolution approval through NSDL's e-voting platform.
 no imag found
04Feb 26
Indraprastha Medical Corporation Reports Q3FY26 Financial Results with Strong Performance
Indraprastha Medical Corporation Limited reported Q3FY26 revenue of ₹378.76 crore and net profit of ₹41.00 crore, showing growth from the previous year. Nine-month revenue reached ₹1159.12 crore with net profit of ₹141.92 crore. The company maintained stable operations with EPS of ₹4.47 for the quarter and ₹15.48 for nine months, reflecting consistent performance in the healthcare sector.
 no imag found
01Nov 25
Indraprastha Medical Corp Reports Revenue Growth to Rs 3.8B in Q2
Indraprastha Medical Corporation Limited, operating Indraprastha Apollo Hospitals, has reported significant financial growth in Q2. Revenue increased to ₹3.80 billion from ₹3.50 billion year-over-year. EBITDA rose to ₹713.00 million from ₹636.00 million, with an improved EBITDA margin of 18.72%. Net profit grew by 16.60% to ₹494.60 crore. The company's Board of Directors approved these unaudited financial results in a recent meeting.
 no imag found
08Oct 25
Indraprastha Medical Shares Soar to All-Time High on CGHS Tariff Revision
Indraprastha Medical Corporation's shares have reached an all-time high of Rs 624.00, driven by a significant revision in Central Government Health Services (CGHS) tariffs. The stock has gained over 30% in 2 days, nearly 40% in 5 days, and 44% over the past 12 months. The CGHS has announced its largest tariff revision in 15 years, increasing rates by 5-30% for nearly 2,000 medical procedures. This is expected to positively impact the company's financials, particularly in specialties like Orthopaedics, Cardiology, and Oncology. However, the stock's RSI of 82.00 suggests potential overbought conditions.
 no imag found
06Aug 25
Indraprastha Medical Corp Reports Robust Q1 Performance with 15% Net Profit Growth
Indraprastha Medical Corporation Limited, operating as Indraprastha Apollo Hospitals, announced robust Q1 results. EBITDA increased to ₹726.00 million from ₹680.00 million year-over-year, with EBITDA margin rising to 19.89%. Net profit grew by 15% to ₹515.00 million, and revenue rose to ₹3.70 billion. The company reported a 4.94% increase in revenue from operations and a 14.94% increase in profit after tax. The Board of Directors made key corporate governance decisions, including new appointments and scheduling the 37th Annual General Meeting.
 no imag found
16May 25
Indraprastha Medical Corp Reports Strong Q4 Results, Declares Dividend
Indraprastha Medical Corp announced impressive Q4 financial results with EBITDA rising to ₹615.00 million from ₹484.00 million year-over-year. Net profit increased to ₹410.00 million, up 31.41% YoY. Revenue grew by 5.10% to ₹3.30 billion. The company declared a dividend of ₹4.50 per equity share. Annual performance showed significant growth with revenue up 13.79%, EBITDA up 30.80%, and net profit up 44.02% YoY. EPS increased from ₹9.40 to ₹13.52, and operating profit margin improved to 15.53% from 13.72%.
 no imag found
1 Year Returns:-10.13%
Industry Peers
Apollo Hospitals
8,082.50
(-0.45%)
Max Healthcare Institute
1,050.10
(+0.05%)
Fortis Healthcare
963.65
(-0.72%)
Aster DM Healthcare
753.65
(+0.94%)
Narayana Hrudayalaya
1,841.10
(+1.19%)
Global Health
1,242.50
(+2.52%)
Park Medi World
244.46
(-1.66%)